<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">FAS</journal-id>
<journal-id journal-id-type="hwp">spfas</journal-id>
<journal-title>Foot &amp; Ankle Specialist</journal-title>
<issn pub-type="ppub">1938-6400</issn>
<issn pub-type="epub">1938-7636</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1938640012451317</article-id>
<article-id pub-id-type="publisher-id">10.1177_1938640012451317</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letter to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Pain Management in Patients with Diabetic Nephropathy</article-title>
<subtitle>The Emerging Role of α-Lipoic Acid</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Kapoor</surname><given-names>Shailendra</given-names></name>
<degrees>MD</degrees>
</contrib>
</contrib-group>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2012</year>
</pub-date>
<volume>5</volume>
<issue>4</issue>
<fpage>228</fpage>
<lpage>229</lpage>
<permissions>
<copyright-statement>© 2012 The Author(s)</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>Dear Editor</p>
<p>I read with great interest the recent article by Suder and Wukich<sup><xref ref-type="bibr" rid="bibr1-1938640012451317">1</xref></sup> in a recent issue of your esteemed journal. The article is highly thought provoking. Interestingly, the past few years have seen the emergence of a number of novel new agents for the management of diabetic neuropathy. One such emerging agent with significant potential in the management of diabetic neuropathy is α-lipoic acid (ALA).</p>
<p>For instance, the SYDNEY study showed that intravenous administration of ALA resulted in significant amelioration of pain in patients with diabetic neuropathy.<sup><xref ref-type="bibr" rid="bibr2-1938640012451317">2</xref></sup> Response rates as high as 53% have been seen after intravenous administration.<sup><xref ref-type="bibr" rid="bibr3-1938640012451317">3</xref></sup> When administered orally, ALA in a daily dose of 600 mg seems to be safe and effective.<sup><xref ref-type="bibr" rid="bibr4-1938640012451317">4</xref></sup> ALA exerts these pain-ameliorating effects by attenuating the glycation process in peripheral neurons.<sup><xref ref-type="bibr" rid="bibr5-1938640012451317">5</xref></sup> Treatment with ALA is also less expensive and is associated with fewer side effects in comparison with other routinely used agents such as gabapentin.<sup><xref ref-type="bibr" rid="bibr6-1938640012451317">6</xref></sup>
</p>
<p>α-Lipoic acid can also be combined with other antioxidants such as superoxide dismutase resulting in drug combinations that result in significant subjective and physiological improvements in patients with diabetic neuropathy.<sup><xref ref-type="bibr" rid="bibr7-1938640012451317">7</xref></sup> Similarly, the neuroprotective effects of ALA are significantly enhanced when it is administered in combination with dipyridamole.<sup><xref ref-type="bibr" rid="bibr8-1938640012451317">8</xref></sup> Interestingly, ALA is more effective in younger adults and females.<sup><xref ref-type="bibr" rid="bibr9-1938640012451317">9</xref></sup>
</p>
<p>Besides these peripheral neuropathic effects, ALA also decreases the effects of autonomic neuropathy in internal tissue such as cardiac and gastric tissue.<sup><xref ref-type="bibr" rid="bibr10-1938640012451317">10</xref></sup> There is a clear need to increase education among physicians about these effects of ALA. Hopefully, this will result in better management of pain in patients with diabetic neuropathy.</p>
<sig-block>
<sig>Shailendra Kapoor, MD</sig>
</sig-block>
</body>
<back>
<ref-list>
<ref id="bibr1-1938640012451317">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Suder</surname><given-names>NC</given-names></name>
<name><surname>Wukich</surname><given-names>D</given-names></name>
</person-group>. <article-title>Prevalence of diabetic neuropathy in patients undergoing foot and ankle surgery</article-title>. <source>Foot Ankle Spec</source>. <year>2012</year>;<volume>5</volume>:<fpage>97</fpage>-<lpage>101</lpage>.</citation>
</ref>
<ref id="bibr2-1938640012451317">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ametov</surname><given-names>AS</given-names></name>
<name><surname>Barinov</surname><given-names>A</given-names></name>
<name><surname>Dyck</surname><given-names>PJ</given-names></name><etal/>
</person-group>; <collab>SYDNEY Trial Study Group</collab>. <article-title>The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial</article-title>. <source>Diabetes Care</source>. <year>2003</year>;<volume>26</volume>:<fpage>770</fpage>-<lpage>776</lpage>.</citation>
</ref>
<ref id="bibr3-1938640012451317">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ziegler</surname><given-names>D</given-names></name>
<name><surname>Nowak</surname><given-names>H</given-names></name>
<name><surname>Kempler</surname><given-names>P</given-names></name>
<name><surname>Vargha</surname><given-names>P</given-names></name>
<name><surname>Low</surname><given-names>PA</given-names></name>
</person-group>. <article-title>Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis</article-title>. <source>Diabet Med</source>. <year>2004</year>;<volume>21</volume>:<fpage>114</fpage>-<lpage>121</lpage>.</citation>
</ref>
<ref id="bibr4-1938640012451317">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ziegler</surname><given-names>D</given-names></name>
<name><surname>Ametov</surname><given-names>A</given-names></name>
<name><surname>Barinov</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial</article-title>. <source>Diabetes Care</source>. <year>2006</year>;<volume>29</volume>:<fpage>2365</fpage>-<lpage>2370</lpage>.</citation>
</ref>
<ref id="bibr5-1938640012451317">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vallianou</surname><given-names>N</given-names></name>
<name><surname>Evangelopoulos</surname><given-names>A</given-names></name>
<name><surname>Koutalas</surname><given-names>P</given-names></name>
</person-group>. <article-title>Alpha-lipoic acid and diabetic neuropathy</article-title>. <source>Rev Diabet Stud</source>. <year>2009</year>;<volume>6</volume>:<fpage>230</fpage>-<lpage>236</lpage>.</citation>
</ref>
<ref id="bibr6-1938640012451317">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ruessmann</surname><given-names>HJ</given-names></name>
</person-group>, <collab>German Society of Outpatient Diabetes Centres AND (Arbeitsgemeinschaft niedergelassener diabetologisch tatiger Arzte e.V.)</collab>. <article-title>Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients</article-title>. <source>J Diabetes Complications</source>. <year>2009</year>;<volume>23</volume>:<fpage>174</fpage>-<lpage>177</lpage>.</citation>
</ref>
<ref id="bibr7-1938640012451317">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bertolotto</surname><given-names>F</given-names></name>
<name><surname>Massone</surname><given-names>A</given-names></name>
</person-group>. <article-title>Combination of alpha lipoic acid and superoxide dismutase leads to physiological and symptomatic improvements in diabetic neuropathy</article-title>. <source>Drugs R D</source>. <year>2012</year>;<volume>12</volume>:<fpage>29</fpage>-<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr8-1938640012451317">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Al-Zamil</surname><given-names>MK</given-names></name>
</person-group>. <article-title>The use of dipyridamole (curantyl) in combination with alpha-lipoic acid in the treatment of diabetic neuropathy with retinopathy</article-title>. <source>Zh Nevrol Psikhiatr Im S S Korsakova</source>. <year>2008</year>;<volume>108</volume>:<fpage>23</fpage>-<lpage>26</lpage>.</citation>
</ref>
<ref id="bibr9-1938640012451317">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Negrisanu</surname><given-names>G</given-names></name>
<name><surname>Rosu</surname><given-names>M</given-names></name>
<name><surname>Bolte</surname><given-names>B</given-names></name>
<name><surname>Lefter</surname><given-names>D</given-names></name>
<name><surname>Dabelea</surname><given-names>D</given-names></name>
</person-group>. <article-title>Effects of 3-month treatment with the antioxidant alpha-lipoic acid in diabetic peripheral neuropathy</article-title>. <source>Rom J Intern Med</source>. <year>1999</year>;<volume>37</volume>:<fpage>297</fpage>-<lpage>306</lpage>.</citation>
</ref>
<ref id="bibr10-1938640012451317">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gibson</surname><given-names>TM</given-names></name>
<name><surname>Cotter</surname><given-names>MA</given-names></name>
<name><surname>Cameron</surname><given-names>NE</given-names></name>
</person-group>. <article-title>Effects of alpha-lipoic acid on impaired gastric fundus innervation in diabetic rats</article-title>. <source>Free Radic Biol Med</source>. <year>2003</year>;<volume>35</volume>:<fpage>160</fpage>-<lpage>168</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>